Warning Letter — New Green Nutrition Inc.
The FDA issued a Warning Letter to New Green Nutrition Inc. following an evaluation by the Center for Drug Evaluation and Research (CDER). Details regarding specific product violations were not explicitly detailed in the provided excerpt but led to formal enforcement action.
This action affects New Green Nutrition Inc. and its regulatory, quality, and marketing departments responsible for product claims and labeling.
The involvement of CDER suggests that the company may be marketing products with therapeutic claims that classify them as unapproved new drugs. This indicates a potential failure to distinguish between dietary supplement health claims and drug claims, which can lead to significant regulatory hurdles including product seizures or injunctions if not remediated.
Review all consumer-facing digital content, including social media and third-party links, to ensure no therapeutic or disease-treatment claims are being made. Conduct a gap analysis between current labeling and FDA drug definitions to prevent unintentional classification of supplements as unapproved new drugs.
FDA Warning Letter issued to: New Green Nutrition Inc.. 10/26/2026 — Center for Drug Evaluation and Research (CDER). Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/new-green-nutrition-inc-737576-10262026
Open in openFDA / FDA.gov